FRESENIUS MEDICAL CARE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.4 EUR | +4.18% |
|
+2.90% | +6.43% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 19.6B 21.11B | Sales 2025 * | 20.39B 21.96B | Capitalization | 11.85B 12.77B |
|---|---|---|---|---|---|
| Net income 2024 * | 694M 747M | Net income 2025 * | 972M 1.05B | EV / Sales 2024 * | 1.11 x |
| Net Debt 2024 * | 9.86B 10.62B | Net Debt 2025 * | 9.07B 9.77B | EV / Sales 2025 * | 1.03 x |
| P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
12.3
x | Employees | 117,128 |
| Yield 2024 * |
1.98% | Yield 2025 * |
3.23% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
| 1 day | +4.18% | ||
| 1 week | +2.90% | ||
| Current month | +2.02% | ||
| 1 month | +13.20% | ||
| 3 months | +9.22% | ||
| 6 months | +26.33% | ||
| Current year | +6.43% |
1 week
36.57
40.95
1 month
34.8740.95
Current year
33.8841.62
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 40.4 | +4.18% | 637,324 |
| 24-05-09 | 38.78 | +0.28% | 221,903 |
| 24-05-08 | 38.67 | +3.31% | 497,225 |
| 24-05-07 | 37.43 | -5.50% | 1,303,398 |
| 24-05-06 | 39.61 | +0.89% | 211,711 |
Delayed Quote Xetra, May 10, 2024 at 11:36 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-05-16
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.78
EUR
Average target price
39.45
EUR
Spread / Average Target
+1.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.43% | 12.26B | |
| +20.68% | 84.31B | |
| -29.31% | 69.9B | |
| +9.65% | 29.06B | |
| -8.63% | 17.38B | |
| +2.14% | 17.01B | |
| +0.39% | 15.35B | |
| +6.47% | 12.91B | |
| +68.23% | 12.47B | |
| +31.27% | 12.1B |
- Stock Market
- Equities
- FME Stock